

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ADP metabolic process (GO:0046031) | 7.86276275 |
| 2 | tolerance induction (GO:0002507) | 7.60230870 |
| 3 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 6.99292737 |
| 4 | T-helper cell differentiation (GO:0042093) | 6.99292737 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 6.78740071 |
| 6 | hair cycle (GO:0042633) | 6.72720660 |
| 7 | molting cycle (GO:0042303) | 6.72720660 |
| 8 | response to interleukin-15 (GO:0070672) | 6.45529391 |
| 9 | interferon-gamma production (GO:0032609) | 6.25748708 |
| 10 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 6.05533036 |
| 11 | alpha-beta T cell activation involved in immune response (GO:0002287) | 6.05533036 |
| 12 | T cell differentiation involved in immune response (GO:0002292) | 6.05533036 |
| 13 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 5.99086155 |
| 14 | positive regulation of heat generation (GO:0031652) | 5.75151437 |
| 15 | regulation of fever generation (GO:0031620) | 5.74436715 |
| 16 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 5.71513398 |
| 17 | NIK/NF-kappaB signaling (GO:0038061) | 5.62621243 |
| 18 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 5.62250763 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.61682526 |
| 20 | negative regulation of cell killing (GO:0031342) | 5.61682526 |
| 21 | cellular response to nicotine (GO:0071316) | 5.35777148 |
| 22 | positive regulation of prostaglandin secretion (GO:0032308) | 5.13048714 |
| 23 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 4.85035784 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.84537353 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.77517786 |
| 26 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 4.75756478 |
| 27 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 4.74575734 |
| 28 | purine nucleoside diphosphate metabolic process (GO:0009135) | 4.74575734 |
| 29 | regulation of prostaglandin secretion (GO:0032306) | 4.73433498 |
| 30 | purine deoxyribonucleotide metabolic process (GO:0009151) | 4.62806427 |
| 31 | regulation of germinal center formation (GO:0002634) | 4.56379095 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 4.52522632 |
| 33 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 4.49836992 |
| 34 | regulation of heat generation (GO:0031650) | 4.48136965 |
| 35 | mast cell degranulation (GO:0043303) | 4.47672435 |
| 36 | mast cell activation involved in immune response (GO:0002279) | 4.47672435 |
| 37 | negative thymic T cell selection (GO:0045060) | 4.44640848 |
| 38 | mast cell activation (GO:0045576) | 4.42939402 |
| 39 | DNA deamination (GO:0045006) | 4.41398762 |
| 40 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.40469139 |
| 41 | alpha-beta T cell differentiation (GO:0046632) | 4.39980438 |
| 42 | Peyers patch development (GO:0048541) | 4.37520301 |
| 43 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.37520301 |
| 44 | negative T cell selection (GO:0043383) | 4.34888893 |
| 45 | sleep (GO:0030431) | 4.33258074 |
| 46 | negative regulation of mast cell activation (GO:0033004) | 4.32774123 |
| 47 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.29210079 |
| 48 | T cell activation involved in immune response (GO:0002286) | 4.28142745 |
| 49 | response to muramyl dipeptide (GO:0032495) | 4.27191893 |
| 50 | alpha-beta T cell activation (GO:0046631) | 4.22363263 |
| 51 | rRNA catabolic process (GO:0016075) | 4.08335340 |
| 52 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 4.07631515 |
| 53 | AMP metabolic process (GO:0046033) | 4.06897078 |
| 54 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 4.05296481 |
| 55 | N-glycan processing (GO:0006491) | 4.05205185 |
| 56 | piRNA metabolic process (GO:0034587) | 3.99305074 |
| 57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.92464772 |
| 58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.90705712 |
| 59 | entrainment of circadian clock by photoperiod (GO:0043153) | 3.90548487 |
| 60 | positive regulation of bone resorption (GO:0045780) | 3.84776767 |
| 61 | positive regulation of bone remodeling (GO:0046852) | 3.84776767 |
| 62 | regulation of cilium movement (GO:0003352) | 3.84409342 |
| 63 | viral protein processing (GO:0019082) | 3.81593393 |
| 64 | natural killer cell activation (GO:0030101) | 3.80346645 |
| 65 | positive regulation of icosanoid secretion (GO:0032305) | 3.79927887 |
| 66 | lymph node development (GO:0048535) | 3.79902521 |
| 67 | multicellular organism reproduction (GO:0032504) | 3.77475948 |
| 68 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.73751155 |
| 69 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.73751155 |
| 70 | isotype switching (GO:0045190) | 3.73751155 |
| 71 | ribonucleoside diphosphate metabolic process (GO:0009185) | 3.71304297 |
| 72 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.69646406 |
| 73 | regulation of response to interferon-gamma (GO:0060330) | 3.68150939 |
| 74 | thymic T cell selection (GO:0045061) | 3.63112983 |
| 75 | lysosome localization (GO:0032418) | 3.61793625 |
| 76 | monocyte chemotaxis (GO:0002548) | 3.58534237 |
| 77 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.58398677 |
| 78 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.58398677 |
| 79 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.57985708 |
| 80 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.56680179 |
| 81 | * positive regulation of osteoclast differentiation (GO:0045672) | 3.55422997 |
| 82 | mature B cell differentiation involved in immune response (GO:0002313) | 3.51741804 |
| 83 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.48275075 |
| 84 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.48275075 |
| 85 | growth hormone receptor signaling pathway (GO:0060396) | 3.47664154 |
| 86 | myeloid dendritic cell differentiation (GO:0043011) | 3.47301776 |
| 87 | regulation of RIG-I signaling pathway (GO:0039535) | 3.45998505 |
| 88 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.43989165 |
| 89 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.43490371 |
| 90 | magnesium ion transport (GO:0015693) | 3.43044751 |
| 91 | L-fucose catabolic process (GO:0042355) | 3.41582308 |
| 92 | fucose catabolic process (GO:0019317) | 3.41582308 |
| 93 | L-fucose metabolic process (GO:0042354) | 3.41582308 |
| 94 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.38203160 |
| 95 | negative regulation of protein autophosphorylation (GO:0031953) | 3.36188484 |
| 96 | T cell selection (GO:0045058) | 3.34554813 |
| 97 | male meiosis (GO:0007140) | 3.34340585 |
| 98 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.24218093 |
| 99 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 3.23330278 |
| 100 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.23075226 |
| 101 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.21937845 |
| 102 | T cell costimulation (GO:0031295) | 3.21056289 |
| 103 | positive thymic T cell selection (GO:0045059) | 3.19266660 |
| 104 | mammary gland epithelial cell proliferation (GO:0033598) | 3.18459205 |
| 105 | estrogen biosynthetic process (GO:0006703) | 3.17756687 |
| 106 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.17002185 |
| 107 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.16009434 |
| 108 | myeloid dendritic cell activation (GO:0001773) | 3.15358980 |
| 109 | negative regulation of inclusion body assembly (GO:0090084) | 3.14426074 |
| 110 | polyamine biosynthetic process (GO:0006596) | 3.13726982 |
| 111 | lymphocyte costimulation (GO:0031294) | 3.13524791 |
| 112 | mature B cell differentiation (GO:0002335) | 3.13022420 |
| 113 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.12774090 |
| 114 | photoperiodism (GO:0009648) | 3.11550619 |
| 115 | positive regulation of circadian rhythm (GO:0042753) | 3.10691248 |
| 116 | T cell differentiation (GO:0030217) | 3.09861646 |
| 117 | * regulation of cell killing (GO:0031341) | 3.09333374 |
| 118 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.09097488 |
| 119 | cytidine deamination (GO:0009972) | 3.08512754 |
| 120 | cytidine metabolic process (GO:0046087) | 3.08512754 |
| 121 | cytidine catabolic process (GO:0006216) | 3.08512754 |
| 122 | adenosine metabolic process (GO:0046085) | 3.08055602 |
| 123 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.07858671 |
| 124 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.06888894 |
| 125 | positive regulation of p38MAPK cascade (GO:1900745) | 3.06572874 |
| 126 | regulation of natural killer cell differentiation (GO:0032823) | 3.05938191 |
| 127 | negative regulation of bone resorption (GO:0045779) | 3.05228013 |
| 128 | positive regulation of T cell cytokine production (GO:0002726) | 3.03358804 |
| 129 | * regulation of memory T cell differentiation (GO:0043380) | 3.02766486 |
| 130 | entrainment of circadian clock (GO:0009649) | 3.01036665 |
| 131 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.00998219 |
| 132 | DNA methylation involved in gamete generation (GO:0043046) | 2.99956912 |
| 133 | bone resorption (GO:0045453) | 2.99908715 |
| 134 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.99846869 |
| 135 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.98668428 |
| 136 | production of molecular mediator of immune response (GO:0002440) | 2.98501556 |
| 137 | lipid storage (GO:0019915) | 2.98491325 |
| 138 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.98003241 |
| 139 | regulation of hypersensitivity (GO:0002883) | 2.97912814 |
| 140 | ncRNA catabolic process (GO:0034661) | 2.97521828 |
| 141 | cellular response to growth hormone stimulus (GO:0071378) | 2.96939846 |
| 142 | positive regulation of macrophage differentiation (GO:0045651) | 2.96254379 |
| 143 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.96121429 |
| 144 | histone H2A monoubiquitination (GO:0035518) | 2.96045058 |
| 145 | positive regulation of fatty acid transport (GO:2000193) | 2.94012833 |
| 146 | regulation of icosanoid secretion (GO:0032303) | 2.93430985 |
| 147 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.93030333 |
| 148 | regulation of thymocyte apoptotic process (GO:0070243) | 2.92060801 |
| 149 | cellular response to interleukin-6 (GO:0071354) | 2.91360976 |
| 150 | diacylglycerol metabolic process (GO:0046339) | 2.89561994 |
| 151 | reproduction (GO:0000003) | 2.89508681 |
| 152 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.88905208 |
| 153 | regulation of chronic inflammatory response (GO:0002676) | 2.88707689 |
| 154 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87068095 |
| 155 | negative regulation of sterol transport (GO:0032372) | 2.86192822 |
| 156 | negative regulation of cholesterol transport (GO:0032375) | 2.86192822 |
| 157 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.85681524 |
| 158 | * positive regulation of myeloid leukocyte differentiation (GO:0002763) | 2.84709951 |
| 159 | regulation of translational termination (GO:0006449) | 2.84515716 |
| 160 | negative regulation of T cell mediated immunity (GO:0002710) | 2.84130643 |
| 161 | cellular defense response (GO:0006968) | 2.83991347 |
| 162 | protein polyglutamylation (GO:0018095) | 2.83793756 |
| 163 | germ cell migration (GO:0008354) | 2.82771449 |
| 164 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.81374481 |
| 165 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.80010036 |
| 166 | negative regulation of monooxygenase activity (GO:0032769) | 2.75760385 |
| 167 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.75311024 |
| 168 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.75311024 |
| 169 | * positive regulation of defense response to virus by host (GO:0002230) | 2.74874985 |
| 170 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.72443174 |
| 171 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.71863899 |
| 172 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.70471488 |
| 173 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.67137248 |
| 174 | leukocyte degranulation (GO:0043299) | 2.65720283 |
| 175 | phosphate ion homeostasis (GO:0055062) | 2.65330834 |
| 176 | trivalent inorganic anion homeostasis (GO:0072506) | 2.65330834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.41858921 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.41522597 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.92699054 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 4.40699298 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.36365135 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.04628817 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.64606552 |
| 8 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.61801493 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.57119891 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.50111327 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32475699 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.31055811 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.24954786 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.01861119 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.97503058 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.96493253 |
| 17 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.86111007 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.78637313 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.76713965 |
| 20 | * MYB_26560356_Chip-Seq_TH2_Human | 2.66131892 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.63682663 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.36882717 |
| 23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.30207724 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.27115779 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25436098 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.23609127 |
| 27 | * MYB_26560356_Chip-Seq_TH1_Human | 2.22980195 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16979830 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.07491792 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.03233280 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02411049 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88860571 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.84500118 |
| 34 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.83315364 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82670566 |
| 36 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.78622776 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.72805449 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.70344510 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68637426 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68193967 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.67076756 |
| 42 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.63211618 |
| 43 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.61159953 |
| 44 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.61072083 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58962164 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57646379 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57451808 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57450695 |
| 49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52825337 |
| 50 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.52787167 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52114151 |
| 52 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.51974619 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49693884 |
| 54 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.47720795 |
| 55 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.47474454 |
| 56 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.45131896 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44623074 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44604887 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.44521499 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.44521499 |
| 61 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.42298452 |
| 62 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41294323 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40827383 |
| 64 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.39820378 |
| 65 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.37691727 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35714785 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35319113 |
| 68 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.34473779 |
| 69 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.34431955 |
| 70 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32635053 |
| 71 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.32442521 |
| 72 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.30070946 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29557874 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.29282686 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28808238 |
| 76 | NCOR_22424771_ChIP-Seq_293T_Human | 1.27904993 |
| 77 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.25639773 |
| 78 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25010356 |
| 79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23920010 |
| 80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23098817 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22749861 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22749861 |
| 83 | * MYC_19829295_ChIP-Seq_ESCs_Human | 1.22746913 |
| 84 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.22390761 |
| 85 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.21565873 |
| 86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21389268 |
| 87 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21360489 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19629475 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 1.19351790 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19018237 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18272624 |
| 92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17659432 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16898005 |
| 94 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16462997 |
| 95 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16376993 |
| 96 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.16047281 |
| 97 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.15692890 |
| 98 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.15692890 |
| 99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15118023 |
| 100 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14623246 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.14368445 |
| 102 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13729979 |
| 103 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12955827 |
| 104 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11486670 |
| 105 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11446050 |
| 106 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10766453 |
| 107 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.08707477 |
| 108 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07483848 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06152550 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05406425 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04242837 |
| 112 | AR_20517297_ChIP-Seq_VCAP_Human | 1.03735231 |
| 113 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.03298731 |
| 114 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.02921514 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02724774 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02279231 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02234237 |
| 118 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01551625 |
| 119 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.00081441 |
| 120 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.00073355 |
| 121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99038917 |
| 122 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98921809 |
| 123 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98679858 |
| 124 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98158077 |
| 125 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96673716 |
| 126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94413578 |
| 127 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93874889 |
| 128 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92704311 |
| 129 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92196458 |
| 130 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91772599 |
| 131 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.91747708 |
| 132 | ERA_21632823_ChIP-Seq_H3396_Human | 0.91218371 |
| 133 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91096753 |
| 134 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90754951 |
| 135 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90644687 |
| 136 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89302166 |
| 137 | P300_27268052_Chip-Seq_Bcells_Human | 0.88891610 |
| 138 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.87660010 |
| 139 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.85231174 |
| 140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84919446 |
| 141 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84889043 |
| 142 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.83950348 |
| 143 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.82720225 |
| 144 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82230948 |
| 145 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82029666 |
| 146 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81362806 |
| 147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79717856 |
| 148 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.79547458 |
| 149 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79532031 |
| 150 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79532031 |
| 151 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79281862 |
| 152 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.78780479 |
| 153 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78201060 |
| 154 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.77161553 |
| 155 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76841275 |
| 156 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.76526281 |
| 157 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75918108 |
| 158 | TP53_16413492_ChIP-PET_HCT116_Human | 0.75672102 |
| 159 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74626895 |
| 160 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.73672075 |
| 161 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72327144 |
| 162 | SPI1_23127762_ChIP-Seq_K562_Human | 0.68723562 |
| 163 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68128344 |
| 164 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.66781455 |
| 165 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66515693 |
| 166 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.66299445 |
| 167 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.66179820 |
| 168 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65424244 |
| 169 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.65172857 |
| 170 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65123685 |
| 171 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.62650222 |
| 172 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62575069 |
| 173 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62154907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 5.52505086 |
| 2 | MP0000685_abnormal_immune_system | 4.64386722 |
| 3 | MP0005075_abnormal_melanosome_morpholog | 3.80580775 |
| 4 | MP0005387_immune_system_phenotype | 3.79685206 |
| 5 | MP0001790_abnormal_immune_system | 3.79685206 |
| 6 | MP0004510_myositis | 3.66999989 |
| 7 | MP0009785_altered_susceptibility_to | 3.64419922 |
| 8 | MP0005671_abnormal_response_to | 3.54196497 |
| 9 | MP0003878_abnormal_ear_physiology | 3.36322537 |
| 10 | MP0005377_hearing/vestibular/ear_phenot | 3.36322537 |
| 11 | MP0003724_increased_susceptibility_to | 3.19854868 |
| 12 | MP0004147_increased_porphyrin_level | 3.17592875 |
| 13 | MP0003763_abnormal_thymus_physiology | 3.10613526 |
| 14 | MP0001800_abnormal_humoral_immune | 3.01553212 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.91303147 |
| 16 | * MP0005000_abnormal_immune_tolerance | 2.85084083 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.83323695 |
| 18 | MP0010155_abnormal_intestine_physiology | 2.80035610 |
| 19 | MP0004885_abnormal_endolymph | 2.79282580 |
| 20 | MP0002405_respiratory_system_inflammati | 2.77222219 |
| 21 | * MP0002723_abnormal_immune_serum | 2.69816236 |
| 22 | MP0002277_abnormal_respiratory_mucosa | 2.66114722 |
| 23 | MP0001188_hyperpigmentation | 2.46354018 |
| 24 | MP0003436_decreased_susceptibility_to | 2.42509083 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.42215175 |
| 26 | * MP0001819_abnormal_immune_cell | 2.27962053 |
| 27 | * MP0002420_abnormal_adaptive_immunity | 2.26551455 |
| 28 | MP0002876_abnormal_thyroid_physiology | 2.24506336 |
| 29 | MP0001502_abnormal_circadian_rhythm | 2.13084175 |
| 30 | MP0004947_skin_inflammation | 2.11831475 |
| 31 | MP0005025_abnormal_response_to | 2.10404627 |
| 32 | MP0001849_ear_inflammation | 2.07785109 |
| 33 | MP0001881_abnormal_mammary_gland | 2.05405609 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 2.00510027 |
| 35 | MP0002419_abnormal_innate_immunity | 1.92740348 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.91321238 |
| 37 | MP0001348_abnormal_lacrimal_gland | 1.91250611 |
| 38 | * MP0002398_abnormal_bone_marrow | 1.88917247 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.88580196 |
| 40 | * MP0000716_abnormal_immune_system | 1.88028712 |
| 41 | MP0002933_joint_inflammation | 1.85815591 |
| 42 | MP0003866_abnormal_defecation | 1.85525348 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.80671333 |
| 44 | MP0002102_abnormal_ear_morphology | 1.78104464 |
| 45 | MP0001873_stomach_inflammation | 1.76602954 |
| 46 | MP0005310_abnormal_salivary_gland | 1.76142055 |
| 47 | MP0002254_reproductive_system_inflammat | 1.75540731 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.72337370 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.71229893 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.71122265 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.70090044 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.69630444 |
| 53 | MP0002722_abnormal_immune_system | 1.68864252 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.66270585 |
| 55 | MP0006082_CNS_inflammation | 1.65883563 |
| 56 | MP0002006_tumorigenesis | 1.62624579 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.61708628 |
| 58 | MP0003879_abnormal_hair_cell | 1.60411836 |
| 59 | MP0001765_abnormal_ion_homeostasis | 1.60236224 |
| 60 | MP0001851_eye_inflammation | 1.58528710 |
| 61 | MP0001853_heart_inflammation | 1.57477433 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.57357209 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.54208334 |
| 64 | MP0008872_abnormal_physiological_respon | 1.52346991 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.49474428 |
| 66 | MP0001346_abnormal_lacrimal_gland | 1.48669519 |
| 67 | MP0003303_peritoneal_inflammation | 1.48279801 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.46720705 |
| 69 | * MP0002429_abnormal_blood_cell | 1.41896666 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.40620122 |
| 71 | MP0000490_abnormal_crypts_of | 1.39966764 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.35748628 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.34357754 |
| 74 | MP0001764_abnormal_homeostasis | 1.33635428 |
| 75 | MP0004742_abnormal_vestibular_system | 1.31971076 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.29824876 |
| 77 | MP0005551_abnormal_eye_electrophysiolog | 1.28859930 |
| 78 | MP0000343_altered_response_to | 1.24411897 |
| 79 | MP0002998_abnormal_bone_remodeling | 1.24082022 |
| 80 | MP0004142_abnormal_muscle_tone | 1.23359028 |
| 81 | MP0002009_preneoplasia | 1.23243290 |
| 82 | MP0001529_abnormal_vocalization | 1.23216554 |
| 83 | MP0008007_abnormal_cellular_replicative | 1.22902621 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 1.21893135 |
| 85 | MP0008961_abnormal_basal_metabolism | 1.20276829 |
| 86 | MP0003448_altered_tumor_morphology | 1.16918913 |
| 87 | MP0000371_diluted_coat_color | 1.16007051 |
| 88 | MP0001919_abnormal_reproductive_system | 1.15961405 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 1.12687491 |
| 90 | MP0008469_abnormal_protein_level | 1.12251871 |
| 91 | MP0000858_altered_metastatic_potential | 1.10203764 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 1.10118137 |
| 93 | MP0009764_decreased_sensitivity_to | 1.09886824 |
| 94 | MP0001968_abnormal_touch/_nociception | 1.08770447 |
| 95 | MP0001501_abnormal_sleep_pattern | 1.08145578 |
| 96 | MP0002272_abnormal_nervous_system | 1.06545634 |
| 97 | MP0005389_reproductive_system_phenotype | 1.04514649 |
| 98 | MP0003011_delayed_dark_adaptation | 1.04210675 |
| 99 | MP0003787_abnormal_imprinting | 1.02306623 |
| 100 | MP0010352_gastrointestinal_tract_polyps | 1.00833150 |
| 101 | MP0002163_abnormal_gland_morphology | 0.97658756 |
| 102 | MP0008775_abnormal_heart_ventricle | 0.97507370 |
| 103 | MP0005397_hematopoietic_system_phenotyp | 0.97173370 |
| 104 | MP0001545_abnormal_hematopoietic_system | 0.97173370 |
| 105 | MP0005646_abnormal_pituitary_gland | 0.96328181 |
| 106 | MP0000249_abnormal_blood_vessel | 0.95104838 |
| 107 | MP0008057_abnormal_DNA_replication | 0.93544059 |
| 108 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91105740 |
| 109 | MP0003252_abnormal_bile_duct | 0.90306727 |
| 110 | MP0002736_abnormal_nociception_after | 0.89952098 |
| 111 | MP0005253_abnormal_eye_physiology | 0.89731672 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.89021287 |
| 113 | MP0001243_abnormal_dermal_layer | 0.88784257 |
| 114 | MP0000627_abnormal_mammary_gland | 0.85898271 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.85625324 |
| 116 | MP0000427_abnormal_hair_cycle | 0.84740665 |
| 117 | MP0000609_abnormal_liver_physiology | 0.84486670 |
| 118 | MP0003646_muscle_fatigue | 0.81941187 |
| 119 | MP0005360_urolithiasis | 0.80085488 |
| 120 | MP0005464_abnormal_platelet_physiology | 0.79495090 |
| 121 | MP0003091_abnormal_cell_migration | 0.78997000 |
| 122 | MP0003786_premature_aging | 0.76892281 |
| 123 | MP0002938_white_spotting | 0.75784393 |
| 124 | MP0003950_abnormal_plasma_membrane | 0.73270391 |
| 125 | MP0002928_abnormal_bile_duct | 0.73039502 |
| 126 | MP0005408_hypopigmentation | 0.73023142 |
| 127 | MP0004808_abnormal_hematopoietic_stem | 0.72909604 |
| 128 | MP0000013_abnormal_adipose_tissue | 0.72160773 |
| 129 | MP0001324_abnormal_eye_pigmentation | 0.70227368 |
| 130 | MP0009763_increased_sensitivity_to | 0.69973769 |
| 131 | MP0005332_abnormal_amino_acid | 0.68591556 |
| 132 | MP0004043_abnormal_pH_regulation | 0.68588155 |
| 133 | MP0005636_abnormal_mineral_homeostasis | 0.68261611 |
| 134 | MP0001485_abnormal_pinna_reflex | 0.68163038 |
| 135 | MP0001879_abnormal_lymphatic_vessel | 0.67783074 |
| 136 | MP0010329_abnormal_lipoprotein_level | 0.66209731 |
| 137 | MP0001963_abnormal_hearing_physiology | 0.64334717 |
| 138 | MP0008995_early_reproductive_senescence | 0.64143484 |
| 139 | MP0002396_abnormal_hematopoietic_system | 0.63401245 |
| 140 | MP0005390_skeleton_phenotype | 0.63268027 |
| 141 | MP0006292_abnormal_olfactory_placode | 0.62399102 |
| 142 | MP0001929_abnormal_gametogenesis | 0.61630358 |
| 143 | MP0005083_abnormal_biliary_tract | 0.61592238 |
| 144 | MP0003795_abnormal_bone_structure | 0.61246670 |
| 145 | MP0008873_increased_physiological_sensi | 0.60138096 |
| 146 | MP0010307_abnormal_tumor_latency | 0.59920928 |
| 147 | MP0009278_abnormal_bone_marrow | 0.59681754 |
| 148 | MP0009765_abnormal_xenobiotic_induced | 0.59565035 |
| 149 | MP0001119_abnormal_female_reproductive | 0.59129906 |
| 150 | MP0000477_abnormal_intestine_morphology | 0.58142156 |
| 151 | MP0002019_abnormal_tumor_incidence | 0.57249906 |
| 152 | MP0001727_abnormal_embryo_implantation | 0.54821552 |
| 153 | MP0002136_abnormal_kidney_physiology | 0.52880513 |
| 154 | MP0000350_abnormal_cell_proliferation | 0.52736576 |
| 155 | MP0003828_pulmonary_edema | 0.52166277 |
| 156 | MP0005164_abnormal_response_to | 0.50099872 |
| 157 | MP0005621_abnormal_cell_physiology | 0.49241332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased density of long bones (HP:0006392) | 7.79438359 |
| 2 | Persistence of primary teeth (HP:0006335) | 6.83070988 |
| 3 | IgM deficiency (HP:0002850) | 6.02513341 |
| 4 | Brittle hair (HP:0002299) | 5.53267783 |
| 5 | Hypophosphatemic rickets (HP:0004912) | 5.22472935 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 4.98723721 |
| 7 | Abnormality of T cell number (HP:0011839) | 4.97100818 |
| 8 | Thyroiditis (HP:0100646) | 4.93839625 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.79676434 |
| 10 | IgA deficiency (HP:0002720) | 4.73786129 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.73229806 |
| 12 | T lymphocytopenia (HP:0005403) | 4.49098947 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.41162678 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 4.41162678 |
| 15 | Abnormality of hair growth rate (HP:0011363) | 4.31458911 |
| 16 | Slow-growing hair (HP:0002217) | 4.31458911 |
| 17 | Renal cortical cysts (HP:0000803) | 4.27076403 |
| 18 | Abnormality of B cell number (HP:0010975) | 4.23135944 |
| 19 | B lymphocytopenia (HP:0010976) | 4.23135944 |
| 20 | Combined immunodeficiency (HP:0005387) | 4.17613854 |
| 21 | Abnormality of T cells (HP:0002843) | 4.12089206 |
| 22 | Abnormality of eosinophils (HP:0001879) | 4.09173721 |
| 23 | Recurrent bronchitis (HP:0002837) | 4.05905227 |
| 24 | Hypotrichosis (HP:0001006) | 4.04345104 |
| 25 | Chronic diarrhea (HP:0002028) | 3.93907570 |
| 26 | Thyroid-stimulating hormone excess (HP:0002925) | 3.93596589 |
| 27 | Premature loss of primary teeth (HP:0006323) | 3.91594528 |
| 28 | Joint swelling (HP:0001386) | 3.90528437 |
| 29 | Rhinitis (HP:0012384) | 3.81291294 |
| 30 | * Pulmonary infiltrates (HP:0002113) | 3.79643070 |
| 31 | * Myositis (HP:0100614) | 3.77428006 |
| 32 | Gastrointestinal stroma tumor (HP:0100723) | 3.74149221 |
| 33 | * Vasculitis (HP:0002633) | 3.69974643 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 3.63928984 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 3.61412034 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.46731633 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 3.46380174 |
| 38 | IgG deficiency (HP:0004315) | 3.42980245 |
| 39 | * Retrobulbar optic neuritis (HP:0100654) | 3.38805253 |
| 40 | * Optic neuritis (HP:0100653) | 3.38805253 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.36273923 |
| 42 | * Orchitis (HP:0100796) | 3.29449503 |
| 43 | Abnormality of the fingertips (HP:0001211) | 3.23794339 |
| 44 | Type II lissencephaly (HP:0007260) | 3.16206723 |
| 45 | Abnormality of dental color (HP:0011073) | 3.16077148 |
| 46 | * Keratoconjunctivitis (HP:0001096) | 3.15622369 |
| 47 | Leukocytosis (HP:0001974) | 3.11937359 |
| 48 | Increased IgE level (HP:0003212) | 3.08966234 |
| 49 | Nephronophthisis (HP:0000090) | 3.01964369 |
| 50 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.96241736 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.96193568 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.92639426 |
| 53 | Increased IgM level (HP:0003496) | 2.88846941 |
| 54 | Autoimmune thrombocytopenia (HP:0001973) | 2.87897408 |
| 55 | Abnormality of the pons (HP:0007361) | 2.84036658 |
| 56 | Recurrent skin infections (HP:0001581) | 2.83127922 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.82293664 |
| 58 | Osteomyelitis (HP:0002754) | 2.81806316 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.81709459 |
| 60 | Esophageal neoplasm (HP:0100751) | 2.78046172 |
| 61 | Neoplasm of head and neck (HP:0012288) | 2.78046172 |
| 62 | * Hemoptysis (HP:0002105) | 2.74648327 |
| 63 | Hypoplasia of the pons (HP:0012110) | 2.73577317 |
| 64 | Abnormal albumin level (HP:0012116) | 2.72413146 |
| 65 | Hypoalbuminemia (HP:0003073) | 2.72413146 |
| 66 | Stomatitis (HP:0010280) | 2.70863926 |
| 67 | Hepatosplenomegaly (HP:0001433) | 2.68452921 |
| 68 | Abnormality of the prostate (HP:0008775) | 2.67979182 |
| 69 | * Keratoconjunctivitis sicca (HP:0001097) | 2.65265283 |
| 70 | Pancreatic cysts (HP:0001737) | 2.61443843 |
| 71 | Xerostomia (HP:0000217) | 2.61104388 |
| 72 | Abnormality of the nasal septum (HP:0000419) | 2.60563456 |
| 73 | Pulmonary fibrosis (HP:0002206) | 2.55042446 |
| 74 | Eosinophilia (HP:0001880) | 2.54238459 |
| 75 | Adactyly (HP:0009776) | 2.52546716 |
| 76 | Congenital stationary night blindness (HP:0007642) | 2.51991838 |
| 77 | Progressive inability to walk (HP:0002505) | 2.51512406 |
| 78 | * Arterial thrombosis (HP:0004420) | 2.50837085 |
| 79 | Poor head control (HP:0002421) | 2.50040975 |
| 80 | Recurrent viral infections (HP:0004429) | 2.49983805 |
| 81 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.49374277 |
| 82 | Tetraparesis (HP:0002273) | 2.49233681 |
| 83 | Facial diplegia (HP:0001349) | 2.47971288 |
| 84 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.45272005 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 2.43257212 |
| 86 | Recurrent bacterial skin infections (HP:0005406) | 2.42641337 |
| 87 | Cheilitis (HP:0100825) | 2.39898303 |
| 88 | Medial flaring of the eyebrow (HP:0010747) | 2.38064452 |
| 89 | Inflammation of the large intestine (HP:0002037) | 2.36259984 |
| 90 | Abnormality of the renal medulla (HP:0100957) | 2.36205983 |
| 91 | Enlarged kidneys (HP:0000105) | 2.34255240 |
| 92 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.33606701 |
| 93 | Conical tooth (HP:0000698) | 2.32813670 |
| 94 | Lymphopenia (HP:0001888) | 2.32604757 |
| 95 | Bronchitis (HP:0012387) | 2.31826258 |
| 96 | * Arthralgia (HP:0002829) | 2.31663150 |
| 97 | Hypoplasia of the uterus (HP:0000013) | 2.30778899 |
| 98 | Vascular calcification (HP:0004934) | 2.29156099 |
| 99 | Hypophosphatemia (HP:0002148) | 2.27840714 |
| 100 | Acrocyanosis (HP:0001063) | 2.27282565 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 2.25797119 |
| 102 | Hydroxyprolinuria (HP:0003080) | 2.25797119 |
| 103 | Attenuation of retinal blood vessels (HP:0007843) | 2.23229158 |
| 104 | Cerebellar dysplasia (HP:0007033) | 2.22930720 |
| 105 | Nasal polyposis (HP:0100582) | 2.22721214 |
| 106 | Lymphoma (HP:0002665) | 2.22134225 |
| 107 | Rickets (HP:0002748) | 2.20511162 |
| 108 | Anhidrosis (HP:0000970) | 2.19819620 |
| 109 | Short tibia (HP:0005736) | 2.18906640 |
| 110 | Abnormality of midbrain morphology (HP:0002418) | 2.17307270 |
| 111 | Molar tooth sign on MRI (HP:0002419) | 2.17307270 |
| 112 | Emphysema (HP:0002097) | 2.16637512 |
| 113 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.16244782 |
| 114 | Acute myeloid leukemia (HP:0004808) | 2.16065522 |
| 115 | Gastrointestinal inflammation (HP:0004386) | 2.15558401 |
| 116 | Depressed nasal tip (HP:0000437) | 2.14718370 |
| 117 | Alveolar cell carcinoma (HP:0006519) | 2.13925792 |
| 118 | Cranial hyperostosis (HP:0004437) | 2.07125783 |
| 119 | Hypergammaglobulinemia (HP:0010702) | 2.06931091 |
| 120 | Flat capital femoral epiphysis (HP:0003370) | 2.06903473 |
| 121 | Granulocytopenia (HP:0001913) | 2.06192000 |
| 122 | Hypochromic anemia (HP:0001931) | 2.05245523 |
| 123 | Asplenia (HP:0001746) | 2.05223980 |
| 124 | Prostate neoplasm (HP:0100787) | 2.03825538 |
| 125 | Stomach cancer (HP:0012126) | 2.03134339 |
| 126 | Obstructive lung disease (HP:0006536) | 2.02976061 |
| 127 | Chronic obstructive pulmonary disease (HP:0006510) | 2.02976061 |
| 128 | Large for gestational age (HP:0001520) | 2.02773897 |
| 129 | Muscle fiber atrophy (HP:0100295) | 2.00628340 |
| 130 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.98637298 |
| 131 | 3-Methylglutaconic aciduria (HP:0003535) | 1.98271251 |
| 132 | Abnormality of macrophages (HP:0004311) | 1.97288408 |
| 133 | Recurrent sinusitis (HP:0011108) | 1.95000453 |
| 134 | * Meningitis (HP:0001287) | 1.93654179 |
| 135 | Fine hair (HP:0002213) | 1.90403667 |
| 136 | Cardiovascular calcification (HP:0011915) | 1.89114713 |
| 137 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.88673589 |
| 138 | Agammaglobulinemia (HP:0004432) | 1.88111747 |
| 139 | Lip pit (HP:0100267) | 1.87587141 |
| 140 | Albinism (HP:0001022) | 1.86456962 |
| 141 | Chronic otitis media (HP:0000389) | 1.86213987 |
| 142 | Abnormality of primary teeth (HP:0006481) | 1.85327064 |
| 143 | Recurrent abscess formation (HP:0002722) | 1.84721110 |
| 144 | Congenital sensorineural hearing impairment (HP:0008527) | 1.84588385 |
| 145 | Hepatic necrosis (HP:0002605) | 1.83706026 |
| 146 | Inability to walk (HP:0002540) | 1.83468503 |
| 147 | Generalized aminoaciduria (HP:0002909) | 1.82131465 |
| 148 | Gingival bleeding (HP:0000225) | 1.80280334 |
| 149 | Chest pain (HP:0100749) | 1.79854308 |
| 150 | Papilledema (HP:0001085) | 1.79527670 |
| 151 | Camptodactyly of toe (HP:0001836) | 1.78705285 |
| 152 | Abnormality of the nasal mucosa (HP:0000433) | 1.78580542 |
| 153 | Vertebral compression fractures (HP:0002953) | 1.77356711 |
| 154 | Cellulitis (HP:0100658) | 1.77234821 |
| 155 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.76951474 |
| 156 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.76654641 |
| 157 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.76654641 |
| 158 | Subacute progressive viral hepatitis (HP:0006572) | 1.76306868 |
| 159 | Tubular atrophy (HP:0000092) | 1.75990920 |
| 160 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.75914862 |
| 161 | Retinal dysplasia (HP:0007973) | 1.73521222 |
| 162 | Bone pain (HP:0002653) | 1.73453619 |
| 163 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.73390059 |
| 164 | Hepatocellular necrosis (HP:0001404) | 1.73204959 |
| 165 | Ileus (HP:0002595) | 1.72633696 |
| 166 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.71907937 |
| 167 | Methylmalonic acidemia (HP:0002912) | 1.70481451 |
| 168 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.70319619 |
| 169 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.67835055 |
| 170 | Neuroendocrine neoplasm (HP:0100634) | 1.66355136 |
| 171 | Nail dystrophy (HP:0008404) | 1.66112747 |
| 172 | Pustule (HP:0200039) | 1.65765802 |
| 173 | Progressive microcephaly (HP:0000253) | 1.64930295 |
| 174 | Myocardial infarction (HP:0001658) | 1.64154122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 6.66409986 |
| 2 | TXK | 6.37324838 |
| 3 | IRAK3 | 5.80033768 |
| 4 | MAP3K14 | 3.74688954 |
| 5 | ZAK | 2.73971334 |
| 6 | JAK1 | 2.71067287 |
| 7 | EPHA3 | 2.62479783 |
| 8 | EPHB1 | 2.54333219 |
| 9 | MAP4K1 | 2.50320632 |
| 10 | ADRBK2 | 2.38789837 |
| 11 | TBK1 | 2.37150962 |
| 12 | TLK1 | 2.35467665 |
| 13 | JAK3 | 2.26557562 |
| 14 | ARAF | 2.24518242 |
| 15 | MAPK15 | 2.08580764 |
| 16 | TSSK6 | 2.07063825 |
| 17 | IKBKE | 1.89377060 |
| 18 | ITK | 1.88361532 |
| 19 | MAP2K2 | 1.84635830 |
| 20 | MAP3K13 | 1.80971610 |
| 21 | CHUK | 1.79720249 |
| 22 | EEF2K | 1.78988887 |
| 23 | TYK2 | 1.78628576 |
| 24 | BCKDK | 1.78048868 |
| 25 | IKBKB | 1.71018462 |
| 26 | TEC | 1.64353897 |
| 27 | KDR | 1.64207103 |
| 28 | FRK | 1.62349020 |
| 29 | STK24 | 1.52969759 |
| 30 | MST4 | 1.50956787 |
| 31 | FGFR3 | 1.50482054 |
| 32 | GRK1 | 1.38267942 |
| 33 | BRD4 | 1.37806077 |
| 34 | BTK | 1.35138455 |
| 35 | PIM1 | 1.33669227 |
| 36 | MAPKAPK5 | 1.33071409 |
| 37 | FGFR4 | 1.29427836 |
| 38 | CDK12 | 1.28442570 |
| 39 | MAP4K2 | 1.24701899 |
| 40 | PINK1 | 1.17993308 |
| 41 | INSRR | 1.16307179 |
| 42 | CLK1 | 1.14927734 |
| 43 | SYK | 1.12691977 |
| 44 | NLK | 1.10646783 |
| 45 | ZAP70 | 1.08097416 |
| 46 | PHKG2 | 1.08068450 |
| 47 | PHKG1 | 1.08068450 |
| 48 | FER | 1.07942532 |
| 49 | MAPK11 | 1.07860114 |
| 50 | MUSK | 1.07682482 |
| 51 | ERBB4 | 0.99879393 |
| 52 | TIE1 | 0.96494888 |
| 53 | HCK | 0.95467465 |
| 54 | STK10 | 0.94466480 |
| 55 | SRPK1 | 0.91470204 |
| 56 | GRK6 | 0.90305399 |
| 57 | SIK3 | 0.85687668 |
| 58 | BMX | 0.80920261 |
| 59 | NUAK1 | 0.80865039 |
| 60 | MELK | 0.79274701 |
| 61 | IRAK4 | 0.78566116 |
| 62 | MAP3K4 | 0.78502251 |
| 63 | MAPKAPK3 | 0.78149844 |
| 64 | WNK4 | 0.76716713 |
| 65 | TRIM28 | 0.76417930 |
| 66 | DMPK | 0.75408089 |
| 67 | JAK2 | 0.74879229 |
| 68 | PRKCQ | 0.73962894 |
| 69 | MAPKAPK2 | 0.71197068 |
| 70 | EIF2AK2 | 0.70702791 |
| 71 | PRKCH | 0.70486829 |
| 72 | CDK9 | 0.67917434 |
| 73 | PRKCI | 0.67140677 |
| 74 | KIT | 0.62166894 |
| 75 | LCK | 0.59945187 |
| 76 | RAF1 | 0.59925554 |
| 77 | CDC7 | 0.58814188 |
| 78 | PRKCE | 0.58329727 |
| 79 | MAPK13 | 0.58026008 |
| 80 | CSF1R | 0.57740040 |
| 81 | RET | 0.56507963 |
| 82 | GSK3A | 0.55762655 |
| 83 | IRAK1 | 0.54317226 |
| 84 | CDK6 | 0.53799051 |
| 85 | MATK | 0.52814101 |
| 86 | TRPM7 | 0.51126499 |
| 87 | WNK3 | 0.49704923 |
| 88 | BCR | 0.49505548 |
| 89 | ERBB3 | 0.48937522 |
| 90 | PLK4 | 0.47104728 |
| 91 | PIK3CA | 0.46781752 |
| 92 | HIPK2 | 0.46602517 |
| 93 | ACVR1B | 0.46422696 |
| 94 | MAP3K6 | 0.43594158 |
| 95 | PTK6 | 0.43260749 |
| 96 | RPS6KA4 | 0.42940236 |
| 97 | LYN | 0.41267208 |
| 98 | RPS6KB1 | 0.40557196 |
| 99 | MAP3K12 | 0.40449631 |
| 100 | BMPR1B | 0.40093301 |
| 101 | BRAF | 0.39865778 |
| 102 | OXSR1 | 0.39725334 |
| 103 | CDK4 | 0.39358011 |
| 104 | SIK2 | 0.38543465 |
| 105 | CDK3 | 0.38376138 |
| 106 | PDGFRB | 0.38190916 |
| 107 | VRK1 | 0.38186822 |
| 108 | STK3 | 0.38098490 |
| 109 | ADRBK1 | 0.37801236 |
| 110 | RPS6KA5 | 0.37685240 |
| 111 | PKN1 | 0.37216025 |
| 112 | MAP3K5 | 0.36451195 |
| 113 | CSNK1G3 | 0.36038218 |
| 114 | MAP3K7 | 0.35842823 |
| 115 | EGFR | 0.34924034 |
| 116 | DYRK1B | 0.33915827 |
| 117 | MAPK7 | 0.33912858 |
| 118 | IGF1R | 0.32696313 |
| 119 | EIF2AK3 | 0.32544552 |
| 120 | ERN1 | 0.32254753 |
| 121 | RPS6KA1 | 0.30874807 |
| 122 | TTK | 0.30722081 |
| 123 | SCYL2 | 0.30670276 |
| 124 | MAP2K1 | 0.30046325 |
| 125 | RPS6KB2 | 0.29201767 |
| 126 | ABL1 | 0.28830029 |
| 127 | FES | 0.28763045 |
| 128 | PAK3 | 0.28753993 |
| 129 | NEK9 | 0.27842594 |
| 130 | NEK2 | 0.26731819 |
| 131 | INSR | 0.26187391 |
| 132 | DYRK2 | 0.24992901 |
| 133 | BMPR2 | 0.22609198 |
| 134 | CHEK2 | 0.22265237 |
| 135 | KSR2 | 0.20386597 |
| 136 | TGFBR1 | 0.19849080 |
| 137 | MAP3K2 | 0.19547565 |
| 138 | ALK | 0.19489613 |
| 139 | TESK2 | 0.19295218 |
| 140 | PIM2 | 0.16440088 |
| 141 | MARK3 | 0.15163173 |
| 142 | CSK | 0.13427669 |
| 143 | MAPK3 | 0.13359214 |
| 144 | MAPK1 | 0.12905179 |
| 145 | CSNK1A1L | 0.12860177 |
| 146 | NEK6 | 0.11955081 |
| 147 | SGK3 | 0.11572187 |
| 148 | CDC42BPA | 0.11562189 |
| 149 | PRKAA2 | 0.11115669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 5.72193699 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.32906166 |
| 3 | Circadian rhythm_Homo sapiens_hsa04710 | 3.32283464 |
| 4 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 3.02127143 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.94083203 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.93240466 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.92464874 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.86352391 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.61191442 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.60679930 |
| 11 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.49231332 |
| 12 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.47719410 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.41773884 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 2.30349512 |
| 15 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.17144454 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.04616850 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02958213 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.01700605 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.00439973 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98288600 |
| 21 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.93081089 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86600593 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.80050958 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.79713783 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.75685137 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.71327942 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.68729076 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.61467347 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.60456078 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58875183 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56711538 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.54145138 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.51857304 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.49985286 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.49391926 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.47228190 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44899390 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44523776 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.44371891 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.43884989 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43455235 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.41789203 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.40032555 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.39902320 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39087345 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34674988 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29861565 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29599716 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 1.26271888 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.24588986 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13610860 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 1.12891609 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11001697 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10650579 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09397343 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08959612 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06260856 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06234155 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05648031 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05443954 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03178292 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02903990 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.99645977 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98337902 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95658592 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95587302 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95183150 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94593731 |
| 69 | Shigellosis_Homo sapiens_hsa05131 | 0.93841092 |
| 70 | Nicotine addiction_Homo sapiens_hsa05033 | 0.92625751 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92253828 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91053800 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88826999 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86167794 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86107680 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84662948 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83146865 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.82569882 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82257300 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81842061 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81185832 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80992596 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80963493 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80844101 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.80730554 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79216234 |
| 87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77922589 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.77031221 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76466965 |
| 90 | RNA polymerase_Homo sapiens_hsa03020 | 0.74290680 |
| 91 | Purine metabolism_Homo sapiens_hsa00230 | 0.73630156 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73286179 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71238901 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69476503 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67368355 |
| 96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67183883 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67038717 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.66179412 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64308151 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63286699 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61336298 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60181047 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.59240317 |
| 104 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59207302 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58711711 |
| 106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58067205 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.57104923 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.56917197 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56527586 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | 0.53053843 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.52429362 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48910687 |
| 113 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.48396988 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.47537065 |
| 115 | Morphine addiction_Homo sapiens_hsa05032 | 0.46650122 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45968403 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45478952 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.45418405 |
| 119 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.45218820 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.45082757 |
| 121 | RNA degradation_Homo sapiens_hsa03018 | 0.44751687 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44592078 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43653719 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42833058 |
| 125 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42041839 |
| 126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41887167 |
| 127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41609046 |
| 128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41472606 |
| 129 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41168095 |
| 130 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39548102 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38975750 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38178354 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38099186 |
| 134 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36959755 |
| 135 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36648689 |
| 136 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36385088 |
| 137 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35560791 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.35288583 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35015870 |
| 140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34961664 |
| 141 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34608808 |
| 142 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33942523 |
| 143 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.33706850 |
| 144 | Cocaine addiction_Homo sapiens_hsa05030 | 0.33329925 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33020456 |
| 146 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.32801801 |
| 147 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32110488 |
| 148 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31283039 |
| 149 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30084413 |
| 150 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29522268 |
| 151 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28506177 |
| 152 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28413055 |
| 153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28233607 |
| 154 | Focal adhesion_Homo sapiens_hsa04510 | 0.27351925 |
| 155 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26541689 |
| 156 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.25900161 |
| 157 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25423034 |
| 158 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.25302017 |
| 159 | Asthma_Homo sapiens_hsa05310 | 0.24304073 |
| 160 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24202677 |
| 161 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21207346 |
| 162 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.19062634 |
| 163 | Endometrial cancer_Homo sapiens_hsa05213 | 0.18957261 |

